)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Healius
Healius (HLS) investor relations material
Healius AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary22 Oct, 2026
Opening remarks and agenda
Kate McKenzie opened the AGM after confirming a quorum; polls opened for all business and remained open until the meeting ended.
Agenda covered Chair and CEO addresses, general questions and formal business; resolutions were decided by poll, with results to be released on the ASX.
Financial performance review
FY26 revenue rose 2.1% to AUD 1.37bn; underlying EBITDA increased 8.1% to AUD 258.6m and underlying EBIT rose 76.6% to AUD 30.2m.
FY26 average fee growth was 4.0% vs FY25; consumables were 15.3% of revenue vs 16.2% in the prior-year period.
FY26 Genomics revenue rose 16.9%, Vetnostics revenue 3.4% and Clinical Trials revenue 92.9% YoY.
Annualised corporate cost savings reached $24.4m; FY26 labour costs were flat and 49.7% of revenue.
Q1 FY27 pathology revenue rose 1.6% despite episodes falling 4.9%; like-for-like volumes rose 1.1%. Average fee increased 6%, labour costs fell 1.4% and total costs fell 0.5%; FY27 EBIT guidance was reaffirmed.
Board and executive committee updates
Steven Rubic joined the board in December 2025 and Professor Bruce Robinson in February 2026, adding healthcare, growth strategy and operational expertise.
The Chair thanked directors who retired during the year; board succession and the mix of skills, including shareholder-focused capability, remain under review.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Healius
- EBITDA rose 8.1% and EBIT 76.6% on 2.1% revenue growth, with margin gains and cost savings.HLS
H2 2026 - AGM showcased strategic progress, strong shareholder support, and focus on margin improvement.HLSAGM 2025
- FY 2026 EBITDA guidance is $259–264m, with Agilex Biolabs up for sale amid sector funding pressures.HLSTrading update
- Revenue and margins rose on cost savings and digital gains, but net loss widened.HLSH1 2026
- Revenue up 5.7%, EBIT in line with consensus, debt repaid, and high margin targets reaffirmed.HLSH2 2025
- Sale of Lumus Imaging enables debt reduction, special dividend, and renewed pathology focus.HLSAGM 2024
- Revenue up 6.1% with strong segment growth, but Pathology impairment and no final dividend.HLSH2 2024
- High single-digit EBIT margins targeted by 2027 via digital, cost, and diagnostic growth.HLSInvestor Day 2025
- Revenue up 10% to $933.9M; Lumus Imaging sale to fund debt reduction and special dividend.HLSH1 2025
Next Healius earnings date
H1 202717 Feb, 2027
Healius
Next Healius earnings date
H1 202717 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Healius Limited, formerly known as Primary Health Care Ltd, is a healthcare company based in Australia. The company provides a wide range of medical and health-related services, including diagnostic imaging, pathology, IVF centers, day hospitals, and healthcare technology solutions. These services cater to medical practitioners, medical practices, and hospitals across Australia. Healius operates an extensive network of medical and pathology centers, contributing significantly to the healthcare sector. Healius Limited is headquartered in St Leonards, New South Wales, and its shares are listed on the Australian Securities Exchange.